George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
London, UK 29 April 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet need in the treatment of cardiometabolic disease, announces the appointment of Mark Mallon as its new Chief Executive Officer and Board Director, effective immediately. Mark brings an extensive track record of successfully leading the development and commercialization of important, innovative medicines across multiple therapeutic areas including cardiovascular and metabolic diseases. During his 24-year career at AstraZeneca, he held multiple senior leadership roles including Executive Vice President of International and Executive Vice President of Product and Portfolio Strategy. More recently, as CEO and Board Director of Ironwood Pharmaceuticals, Mark led the successful transformation of a largely primary care business towards a company focused on making a difference for patients with serious and rare gastrointestinal diseases, with considerable growth and profit gener
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Rare Blood Clots From J&J, Astra Covid Shots Linked to Genetics [BNN Bloomberg (Canada)]BNN Bloomberg
- OCT Europe: Unless everyone is benefiting, what is the point? [Yahoo! Finance]Yahoo! Finance
- PTEN Research Foundation Further Strengthens its Scientific Advisory Board with the Appointment of Two New Senior Leaders from the Pharmaceutical Industry [Yahoo! Finance]Yahoo! Finance
- Enhanc3D Genomics Appoints Hazel Jones as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 5/15/24 - Form 6-K
- 5/7/24 - Form 6-K
- 5/2/24 - Form 6-K
- AZN's page on the SEC website